T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors
There is an urgent need to discover blood-based biomarkers to predict response to immune checkpoint inhibitors (ICI). Here the authors show that effective ICI therapy correlates with increased frequency of circulating CX3CR1+CD8+ T cells in preclinical tumor models and in a cohort of patients with n...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5ad9763c2d134ba4b389bb215a94772a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!